Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
The Journal of Urology
|
December 21, 2012
An analysis of leukapheresis and central venous catheter use in the randomized, placebo controlled, phase 3 IMPACT trial of Sipuleucel-T for metastatic castrate resistant prostate cancer
Robert C Flanigan, Anthony J Polcari, Neil D Shore, et al.
British Journal of Pharmacology
|
December 22, 1999
Pharmacological characterization of antagonists of the C5a receptor
N J Paczkowski, A M Finch, J B Whitmore, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 2, 2020
TNF-α signaling regulates RUNX1 function in endothelial cells
Hannah A B Whitmore, Dhanesh Amarnani, Michael O'Hare, et al.
The American Journal of Pathology
|
December 21, 2020
Treatment of Experimental Choroidal Neovascularization via RUNX1 Inhibition
Lucia Gonzalez-Buendia, Santiago Delgado-Tirado, Miranda An, et al.
Arthritis and Rheumatism
|
May 30, 2006
Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis
Daniel J Lovell, Andreas Reiff, Olcay Y Jones, et al.
The Journal of Infectious Diseases
|
October 7, 2000
A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS
C Brites, M J Gilbert, D Pedral-Sampaio, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2012
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
Nadeem A Sheikh, Daniel Petrylak, Philip W Kantoff, et al.
Current Medical Research and Opinion
|
January 6, 2006
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study
Allan Gibofsky, William R Palmer, John A Goldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Debraj GuhaThakurta, Nadeem A Sheikh, Li-Qun Fan, et al.
The American Journal of Pathology
|
April 24, 2021
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators
Michael O'Hare, Dhanesh Amarnani, Hannah A B Whitmore, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
The Journal of Urology
|
December 21, 2012
An analysis of leukapheresis and central venous catheter use in the randomized, placebo controlled, phase 3 IMPACT trial of Sipuleucel-T for metastatic castrate resistant prostate cancer
Robert C Flanigan, Anthony J Polcari, Neil D Shore, et al.
British Journal of Pharmacology
|
December 22, 1999
Pharmacological characterization of antagonists of the C5a receptor
N J Paczkowski, A M Finch, J B Whitmore, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 2, 2020
TNF-α signaling regulates RUNX1 function in endothelial cells
Hannah A B Whitmore, Dhanesh Amarnani, Michael O'Hare, et al.
The American Journal of Pathology
|
December 21, 2020
Treatment of Experimental Choroidal Neovascularization via RUNX1 Inhibition
Lucia Gonzalez-Buendia, Santiago Delgado-Tirado, Miranda An, et al.
Arthritis and Rheumatism
|
May 30, 2006
Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis
Daniel J Lovell, Andreas Reiff, Olcay Y Jones, et al.
The Journal of Infectious Diseases
|
October 7, 2000
A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS
C Brites, M J Gilbert, D Pedral-Sampaio, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2012
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
Nadeem A Sheikh, Daniel Petrylak, Philip W Kantoff, et al.
Current Medical Research and Opinion
|
January 6, 2006
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study
Allan Gibofsky, William R Palmer, John A Goldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Debraj GuhaThakurta, Nadeem A Sheikh, Li-Qun Fan, et al.
The American Journal of Pathology
|
April 24, 2021
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators
Michael O'Hare, Dhanesh Amarnani, Hannah A B Whitmore, et al.
Page
of 6